A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer

BACKGROUND. Recent evidence shows that use of anthracycline and taxane adjuvant chemotherapy and dose-dense regimens, consisting of more frequent administration of the drugs, have improved outcomes for breast cancer patients. In this study, we evaluated administration of an epirubicin-based regimen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Pietri, Elisabetta, Andreis, Daniele, Fabbri, Francesca, Menna, Cecilia, Schirone, Alessio, Kopf, Barbara, Rocca, Andrea, Amadori, Dino, De Giorgi, Ugo
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2015
Témata:
Clinical Trial Results
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350798/
https://ncbi.nlm.nih.gov/pubmed/25637379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0326
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky